BRAIN Biotech AG - ESG Rating & Company Profile powered by AI
The SDG assessment for BRAIN Biotech AG represents its transparency towards the United Nations SDGs. Other companies in the scoring industry group for BRAIN Biotech AG are displayedin the table. This webpage is a free Sustainability assessment covering BRAIN Biotech AG.
BRAIN Biotech AG in the Specialty Chemicals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | BRAIN Biotech AG | 8.0 | High |
1 | Cemedine Co Ltd | 8.0 | High |
1 | Chemical and Allied Products PLC | 8.0 | High |
... | ... | ... | |
379 | Zhuzhou Feilu High-Tech Materials Co Ltd | 0.0 | Low |
379 | Zibo Qixiang Tengda Chemical Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does BRAIN Biotech AG have an accelerator or VC vehicle to help deliver innovation?
Does BRAIN Biotech AG disclose current and historical energy intensity?
Does BRAIN Biotech AG report the average age of the workforce?
Does BRAIN Biotech AG reference operational or capital allocation in relation to climate change?
Does BRAIN Biotech AG disclose its ethnicity pay gap?
Does BRAIN Biotech AG disclose cybersecurity risks?
Does BRAIN Biotech AG offer flexible work?
Does BRAIN Biotech AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does BRAIN Biotech AG disclose the number of employees in R&D functions?
Does BRAIN Biotech AG conduct supply chain audits?
Does BRAIN Biotech AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does BRAIN Biotech AG conduct 360 degree staff reviews?
Does BRAIN Biotech AG disclose the individual responsible for D&I?
Does BRAIN Biotech AG disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does BRAIN Biotech AG disclose current and / or historical scope 2 emissions?
Does BRAIN Biotech AG disclose water use targets?
Does BRAIN Biotech AG have careers partnerships with academic institutions?
Did BRAIN Biotech AG have a product recall in the last two years?
Does BRAIN Biotech AG disclose incidents of discrimination?
Does BRAIN Biotech AG allow for Work Councils/Collective Agreements to be formed?
Has BRAIN Biotech AG issued a profit warning in the past 24 months?
Does BRAIN Biotech AG disclose parental leave metrics?
Does BRAIN Biotech AG disclose climate scenario or pathway analysis?
Does BRAIN Biotech AG disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does BRAIN Biotech AG disclose the pay ratio of women to men?
Does BRAIN Biotech AG support suppliers with sustainability related research and development?
Does BRAIN Biotech AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does BRAIN Biotech AG reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is BRAIN Biotech AG involved in embryonic stem cell research?
Does BRAIN Biotech AG disclose GHG and Air Emissions intensity?
Does BRAIN Biotech AG disclose its waste policy?
Does BRAIN Biotech AG report according to TCFD requirements?
Does BRAIN Biotech AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does BRAIN Biotech AG disclose energy use targets?
Does BRAIN Biotech AG disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does BRAIN Biotech AG have a policy relating to cyber security?
Have a different question?
Potential Risks for BRAIN Biotech AG
These potential risks are based on the size, segment and geographies of the company.
BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and nature-based active ingredients for product development in the food, animal feed, skin care, cosmetics, and chemical industries. The company also identifies and develops optimized enzymes and biocatalysts for the production of food and beverages, and wound care preparations or lubricants, as well as for starch processing of bioethanol production; and microorganisms as the functional biomass for optimized industrial production processes, recycling of greenhouse gas CO2 as an industrial raw material, and extraction of precious and rare earth metals. It has strategic partnerships with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.